Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Journal of the National Cancer Institute
|
March 25, 2026
Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma
Yvonne M Geurts, Suzanne I M Neppelenbroek, Berthe M P Aleman, et al.
Haematologica
|
April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
Marie José Kersten, Martin Dreyling, Kim M Linton, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
American Journal of Hematology
|
June 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow, Jon Salmanton-García, Piotr Nowak, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Open Forum Infectious Diseases
|
March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Journal of the National Cancer Institute
|
March 25, 2026
Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma
Yvonne M Geurts, Suzanne I M Neppelenbroek, Berthe M P Aleman, et al.
Haematologica
|
April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
Marie José Kersten, Martin Dreyling, Kim M Linton, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
American Journal of Hematology
|
June 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow, Jon Salmanton-García, Piotr Nowak, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Open Forum Infectious Diseases
|
March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 8